CLINICAL_TRIALS ClinicalTrials.gov record with results posted

Open Label Randomized Clinical Study of Plasmid Encoding p62/SQSTM1 (ELenagen) in in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05979298
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-08-25T00:08:29.588834+00:00
Published At: 2026-08-24T00:00:00+00:00
Record Updated At: 2026-08-24
Results Posted At: 2026-08-24
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Ovarian Cancer", "Platinum-resistant Ovarian Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-08-24"
protocolSection.identificationModule.nctId: "NCT05979298"
protocolSection.identificationModule.officialTitle: "Open Label Randomized Clinical Study of Plasmid Encoding p62/SQSTM1 (ELenagen) in in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Cancer"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2026-08-24"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.